ArticleInternational journal of endocrinology2026
Association Between Iron Metabolism and Microalbuminuria in Patients With Type 2 Diabetes Mellitus and MASLD.
Article in International journal of endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association Between Iron Metabolism and Microalbuminuria in Patients With Type 2 Diabetes Mellitus and MASLD.International journal of endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the association between iron metabolism markers and microalbuminuria in patients with Type 2 diabetes mellitus (T2DM) and metabolic dysfunction-associated steatotic liver disease (MASLD). Methods: A total of 137 patients with T2DM and MASLD were enrolled and stratified into microalbuminuria-positive and microalbuminuria-negative groups based on the urinary albumin-to-creatinine ratio (UACR). Iron metabolism markers, including serum ferritin, serum iron, total iron-binding capacity (TIBC), transferrin saturation (TS), and hepcidin, were measured. Hepatic iron and fat content were assessed using magnetic resonance imaging (MRI), including R2 Results: Patients with microalbuminuria had significantly higher levels of serum ferritin, serum iron, hepcidin, and MRI-R2 Conclusions: Altered iron metabolism is associated with microalbuminuria in patients with T2DM and MASLD. MRI-R2
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.